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Abstract: Even though alterations in the microenvironmental properties of tissues 
underlie the development of the most prevalent and morbid pathologies in developed 
countries, they are not directly observable in vivo by conventional Magnetic Resonance 
Imaging (MRI) or Spectroscopy (MRS) methods. This circumstance has lead to the 
development of a wide variety of exogenous paramagnetic and diamagnetic MRI and 
MRS probes able to inform non invasively on microenvironmental variables such as pH, 
pO2, ion concentration o even temperature. This review covers the fundamentals of 
environmental contrast and the current arsenal of endogenous and exogenous MRI and 
MRS contrast enhancing agents available to visualize it. We begin describing briefly the 
physicochemical background necessary to understand paramagnetic and diamagnetic 
contrast enhancement with a special reference to novel Magnetization Transfer and 13C 
Hiperpolarization strategies. We describe then the main macrocyclic structures used to 
support the environmentally sensitive paramagnetic sensors, including CEST and 
PARACEST pH sensitive probes, temperature probes and enzyme activity or gene 
expression activatable probes. Finally we address the most commonly used diamagnetic 
contrast agents including imidazolic derivatives to reveal extracellular pH and tissue 
pO2 values by MRS. The potential applications of these agents in mutimodal and 
molecular imaging approaches are discussed. 
 
Key words: Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Tissue 
Microenvironment, Contrast Mechanisms, Paramagnetic Contrast Agents, Diamagnetic 
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1. INTRODUCTION 
< Figure 1, near here> 
The extracellular space of tissues is located between the cellular architectures 
and the capillary network providing a vital environment for intercellular communication 
and regulatory metabolic interactions (Figure 1). The biochemical profile of this 
compartment modulates many vital intracellular functions including differentiation [1], 
tissue regeneration [2], angiogenesis [3], metastasis [4], proliferation [5] and apoptosis 
[6] or necrosis [7], among others. The extracellular “millieu” is characterized by a 
collection of environmental properties, such as pH, pO2, ionic composition or diffusion, 
which are significantly different from those present in the intracellular or vascular 
spaces, configuring in this way a physiologically distinct compartment (Figure 1). 
Alterations in the environmental properties are known to occur very early during disease 
development, providing precious information for the diagnosis, prognosis and therapy 
assessment of the most prevalent and morbid pathologies in developed countries, with 
particular emphasis in cancer and ischemic episodes [8-10]. On these grounds, non 
invasive imaging of the extracellular microenvironment has gained substantial scientific 
and clinical interest in the last decades [11-13]. The biochemical properties of this 
compartment result from the balance between the cellular uptake and metabolism of 
substrates as glucose and oxygen from the capillaries, and the removal of waste 
products as lactate and H+ through the tissue microvasculature (Figure 1A). Intracellular 
oxidative metabolism leads simultaneously to the production of freely diffusing CO2 
and water (in fast equilibrium with HCO3- and H+ through carbonic anhidrase). 
Reductions in glucose or oxygen delivery either by systemic metabolic limitations or 
inadequate performance of the local capillary network, result in extracellular lactate and 
proton accumulation, two conditions commonly found during the early development of 
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most pathologies (Figure 1B). Environmentally sensitive contrast agents (CA´s) are 
molecules designed to respond to physiopathological alterations in the values of 
extracellular pH, pO2, lactate, glucose, ions as Ca2+ or Zn2+, red-ox state or even 
temperature, in a manner detectable by MRI or MRS methods [14-17]. A variety of 
paramagnetic and diamagnetic “smart CAs” have been designed for this purpose. This 
review provides an integrative overview on the development and properties of these 
agents.  
The first generation of CA´s included highly stable paramagnetic lanthanide 
chelates with linear or macrocyclic ligands derived from diethylendiaminopentaacetic 
acid or tetraazamacrocyclic structures. These complexes, despite proving considerable 
capacity to reduce the relaxation times of tissue water in vivo, remained non specific 
hampering to obtain the microenvironmental information desired from the observed 
contrast enhancement. Improvements in the understanding of the structural and dynamic 
determinants of water relaxation in the presence of paramagnetic chelates, allowed for 
the rational design and synthesis of optimized ligands and chelates with improved 
relaxivity and fine-tuned sensitivity to microenvironmental factors [16,18-20]. Despite 
spectacular improvements, the use of environmentally sensitive paramagnetic chelates 
is, however, not devoid of important drawbacks under in vivo conditions. In particular, 
the relaxivity effects observed may derive frequently, from factors additional to those 
being investigated including the concentration of the probe or the environmental effects 
of microviscosity, limited water diffusion and eventually local temperature changes. 
These uncertainties prompted the development of alternative diamagnetic probes able to 
determine the microenvironmental properties in vivo in the absence if these 
interferences [21]. 
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In parallel with the development of MR imaging strategies, early progress in 
localized Magnetic Resonance Spectroscopy methods, allowed to obtain the metabolic 
fingerprint of healthy and diseased tissues and lesions [22]. The initial in vivo spectra 
localized a single tissue volume, but could soon be resolved in space generating 
multivoxel 1H and 13C MRSI spectroscopic maps with resolution approaching that 
provided by Possitron Emission Tomography (PET) and other nuclear medicine 
techniques [23]. However, as in the case of MRI, the MRS observation of endogenous 
metabolites did not disclose directly the properties of the extracellular environment. 
This made it necessary to synthesize novel collections of “ad hoc” exogenous 
diamagnetic sensors able to reveal, the values of tissue pH and pO2, not previously 
obtainable from the profile of endogenous metabolites.  
In this work we wish to provide an integrative view on the arsenal of 
paramagnetic and diamagnetic contrast agents currently available to investigate the 
tissue microenvironment. We begin by introducing the physicochemical background 
supporting the paramagnetic and diamagnetic strategies of environmental contrast 
enhancement. We then describe the paramagnetic ligands and chelates most commonly 
used in these studies. To finalize, we address the use of environmentally sensitive 
diamagnetic contrast agents currently available for the MRI/MRS approaches. Many 
related topics could not be covered here to make this review compatible with the 
allowed length. In particular, the following literature is recommended to complement 
and extend the information on synthesis and coordination chemistry of macrocyclic 
structures [24-27], their coupling to proteins or antibodies for cell targetting [28,29], 
superpaparamagnetic or ferromagnetic nanoparticles [30,31] or liposome formulations 
[32-34]. A comprehensive perspective on the fundamentals of paramagnetic relaxation 
and the early agents may be found the classical books edited by Merbach and Toth [35] 
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or Krause [36], and in the reviews of refs. [18,37-39]. Earlier accounts on diamagnetic 
probes may be found in [21]. Finally, for comprehensive information in novel 
nanotechnology approaches and liposomal formulations the reader is referred to refs. 
[40-42]. 
 
2. AN INTEGRATIVE VIEW ON PARAMAGNETIC AND DIAMAGNETIC 
CONTRAST  
 Contrast enhancement in MRI or MRS (Δc) may be defined as the difference in 
intensity between the same pixel or the same collection of pixels (region of interest) in 
the pre-contrast (Ipre or Īpre) and post-contrast (Ipost or Īpost) MR images;  
    Δc= Ipre-Ipost  ≈ Īpre- Īpost    (1) 
Enhanced image contrast may be then, produced by any differential manipulation of the 
Ipost intensity, normally achieved through the administration of an adequate exogenous 
contrast agent or probe. Paramagnetic contrast agents increase Δc by modifying the 
relaxation properties of tissue water in the regions where they accumulate, while 
diamagnetic contrast agents enhance spectroscopic images by introducing new 
resonances from the exogenous spectroscopic probe. Notably, both approaches are able 
to induce the same Δc becoming entirely comparable from this perspective. However, 
diamagnetic and paramagnetic contrast agents are normally treated independently in the 
literature. Here we aim to combine both approaches, since both seek to improve Δc. The 
intracellular, extracellular or vascular confinement of the administered diamagnetic or 
paramagnetic probe determines the compartmental origin of image contrast observed. 
Endogenous metabolites are normally considered to have a primarily intracellular 
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origin, while exogenous paramagnetic and diamagnetic probes are thought to enhance 
contrast derived from the extracellular and vascular environments. 
 
3. FUNDAMENTALS OF PARAMAGNETIC CONTRAST ENHANCEMENT  
The ability of paramagnetic probes to increase the relaxation rates r´1,2,2* of 
solvent water is a linear function of the concentration of the contrast agent [CA], the 
slope of which  is known as r1,2,2* relaxivity (measured in s-1.mM-1); 
r´1,2,2* = r01,2,2*+ r1,2,2*[CA]    (2) 
where r01,2, 2* represent the relaxation rate of the water protons in the absence of contrast 
agent [43]. The higher the relaxivity of the probe the more potent and sensitive the agent 
becomes and the smaller the concentration required to obtain MRI detectable changes in 
water relaxation [18].  
< Figure 2, near here> 
The enhancement in the water relaxation rate originates from the direct contact 
of one or more water molecules with the unpaired electron(s) of the paramagnetic metal. 
Paramagnetic contact results in a transfer of electronic magnetization that reduces 
relelaxation times of the coordinated water molecule (T1m), which then exchanges fast 
with the remaining water molecules of the solvent (kex), magnifying enormously the 
effects of the initial paramagnetic interaction. Gd(III) was chosen as the optimal 
paramagnetic lanthanide because of its seven unpaired electrons in d orbitals (the largest 
within the lanthanide series) and its relatively slow electronic relaxation rate (ca. 10ps). 
Both circumstances provide the most intense paramagnetic effect among the lanthanide 
series and the longest electronic magnetization transfer period during the residence time 
of the coordinated water molecule over the paramagnetic ion. However, free Gd(III) 
ions are toxic in vivo, mostly because of their very favourable competition with the 
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endogenous Ca2+ ions necessary for the operation of many biochemical and 
physiological processes. This circumstance imposed, for safety reasons, to use Gd(III) 
chelates with extremely high kinetic and thermodynamic stability, rather than the free, 
hydrated Gd(III) ion [44].  Upon chelation, up to eight sites out of the nine available in 
Gd(III) are occupied by the polydentate ligand, leaving normally only one vacant site 
for water contact and exchange. Even with this precaution, the possibility of 
transmetallation in vivo is not negligible. The competitive substitution of chelated 
Gd(III) by physiologically competing metals (Ca2+, Zn2+ or Mn2+ among others), 
liberating free Gd(III) into the tissue entails considerable risk, probably underlying 
some of the nephrogenic cystic fibrosis cases observed in renally compromised patients 
after repeated administration of some Gd(III) chelates [45-47]. In addition to Gd(III) 
many other paramagnetic metals may be used (although less efficiently) for these 
purposes, including mainly Dy(III), Eu(III), Mn (II) or Fe(III). 
The relaxation enhancement induced in water by paramagnetic ions involves two 
different effects; the inner (ris) and outer (ros) sphere contributions to relaxivity, each 
one representing approximatelly 50% of the total relaxivity observed [18,37,43,48]. 
Inner sphere contributions are due to those water molecules in direct contact with 
Gd(III) ion, while outer  sphere effects involve the contributions of solvent molecules 
external to the complex, but still maintaining an efficient exchange with those of the 
inner sphere. Only the inner sphere effects can be adequately modulated by 
manipulating the chemical structure of the ligand. Very briefly, the relaxation of water 
molecules in the inner sphere of a paramagnetic chelate may be described theoretically 
by an intricate, highly non linear function of the number of water molecules coordinated 
to the paramagnetic metal (q), the correlation time of the complex (τc) and the exchange 
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rate (kex) of water molecules in the inner coordination sphere of the paramagnetic metal 
[18,37,43,48]; 
r1is= f (q, τc, kex)    (3) 
The first improvements in the structure of the ligands agents seeked to improve 
their relaxivity values. Relaxivity of the early chelates lied in the range 3-4 s-1.mM-1, 
being significantly smaller value than the predicted theoretical limit of ca. 100 s-1.mM-1. 
Increasing the q values, slowing down the molecular rotation τc (e.g. by increasing the 
molecular weight of the complexes using dendrimeric materials or binding to 
macromolecules) and favouring a faster water exchange (increased kex), produced 
significant increases in relaxivity reaching the 30-40 s-1 mM-1 range. This knowledge on 
the determinants of relaxivity and their structural basis allowed then for the design of  
activatable probes, showing relaxivity changes in response to environmental factors as 
temperature, pH, metabolites, enzymatic activity or even gene expression through the 
effects of these variables of q, τc or kex, respectively [14,16].  
 
4. FUNDAMENTALS OF DIAMAGNETIC CONTRAST ENHANCEMENT  
In addition to the paramagnetic probes, contrast in Magnetic Resonance Images 
may be improved by diamagnetic methods through the selective perturbation of the 
chemical exchange of endogenous water molecules or the selective enhancements of 
their different diffusional components. Spectroscopic methods add to these classical 
diamagnetic imaging approaches by providing spectroscopic probes sensitive to 
microenvironmental factors as pH or pO2. While it is possible to discriminate between 
the intra- and extracellular environment because of the faster water diffusion in the later, 
perturbations involving water exchange are more difficult to interpret, since 
magnetically labelled water may exchange between the intra- and extracellular 
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environments several times during the measurement time, providing a weighted average 
of the contribution from these two environments. In spite of this, it is normally 
convened in all these cases, that the use of non permeable exogenous probes primarily 
reflects the properties of vascular and extracellular compartments while the use of 
endogenous metabolites reflect mainly the intracellular environment. 
Chemical Exchange 
<Figure 3, near here> 
The most abundant endogenous diamagnetic probe in vivo is the water molecule, 
accounting for approximately 80% of the tissue weight in adult mammals [49]. The 
presence of at least two dynamically different and mutually exchanging types of water 
molecules in vivo, those freely mobile and those trapped as solvation water in 
biomacromolecules, open the possibility to enhance contrast by manipulating this 
exchange [50]. The method is based in the early proposal of Forsen and Hoffman to 
determine exchange rates through saturation transfer experiments  [51]. Free solvent 
water has a fast rotational and translational correlation time ca. 1 ps originating a 
narrow resonance, while solvation water, partially immobilized over the surface of 
macromolecules, acquires the macromolecular rotational and translational dynamics (in 
the ns range) originating a downfield shifted (typically 2-4 ppm), broad, water 
resonance [49]. This dynamic difference underlies an interesting source of MRI contrast 
based in the exchange between these dynamically different environments (Chemical 
Exchange Saturation Transfer, CEST) [52]. First, for this two populations of water 
molecules to be resolved as two resonances, the exchange rate kex between them must 
be slower than the chemical shift difference Δω between both resonances (Δω>>kex). 
Under these conditions, it is possible to saturate the broad component and observe a 
decrease in the intensity of the narrow one. The faster the exchange kex between these 
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populations, the more saturation transfer is observed [53]. However, the exchange rate 
can never exceed the “slow exchange” limit (Δω>>kex), so the approach is inherently 
limited to measure rates slower than Δω, normally few 1H NMR ppm between 
diamagnetic molecules (DIACEST).  Notably, it is possible to increase dramatically 
Δω by using lanthanide “shift reagents”. These molecules are chelates of different 
lanthanides, particularly Eu(III) or Dy(III), able to increase Δω up to ca. 50 ppm, 
improving considerably the range of exchange rates measurable.  Moreover, different 
Δω can be induced using different lanthanides, an opportunity that allows to “fine tune” 
different saturation frequencies for different purposes, through the use different 
lanthanide complexes, even if the same ligand is used. 
The saturation transfer phenomenon is not restricted to exchanges between water 
molecules. In the Amide Proton Transfer (APT) method, the exchange of magnetization 
between the amide protons from tissue peptides and proteins and those of solvent water 
is observed [54]. In these cases it is possible to induce decreases in the solvent water 
resonance intensity after irradiating the amide region, the effect being larger for larger 
protein concentrations, a circumstance that allows the estimation of protein and peptide 
concentrations in vivo [55,56]. 
The exchange of protons between water and the amide protons is pH dependent, 
allowing also the investigation of tissue pH from the exchange rates determined by 
Chemical Exchange Saturation Transfer with a variety of diamagnetic molecules 
including proteins [57-59]. The compartmental origin of the dominant exchange 
mechanism determines the physiological environment where the pH is monitored. In the 
APT method, the pH value visualized corresponds most probably to the intracellular 
compartment, since the intracellular protein and peptide concentrations are larger than 
those in the extracellular space. This approach may be also enhanced to the use of 
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exogenous pH sensitive paramagnetic chelates (PARACEST) [14,16]. In these cases the 
exchange of water molecules between the coordination sphere of the paramagnetic 
center and the bulk solvent is also pH sensitive. Since these probes are mainly 
extracellular, the pH values visualized are thought to correspond primarily to the 
extracellular environment. PARACEST approaches entail enormous versatility since 
different environmental properties may visualized in the same imaging experiment by 
using selective irradiation frequencies of a suitable collection of lanthanide chelates 
with different Δω. In should be possible then to obtain intra- and extracellular pH 
images from the same tissue using endogenous and exogenous CEST and PARACEST 
agents. 
Translational diffusion 
< Figure 4, near here> 
The translational movements of water provide an additional opportunity to 
induce and observe tissue contrast since they can be conveniently monitored by 
diffusion weighted MRI methods [60]. Following the Stokes-Einstein relationship, the 
Apparent translational Diffusion  Coefficient (ADC) of water is highly dependent on the 
molecular obstructions that the water molecule finds in its random movements. These 
obstructions are higher in the intra- than in the extracellular environments, resulting in 
slower intracellular diffusion. Moreover, it has become recently possible to explore the 
translational diffusion of water in any direction of space, simply by modifying the 
orientation of the applied diffusion sensitizing gradient [61]. This made it possible to 
unravel the dominant direction of translational water movements solving the diffusion 
tensor, a procedure allowing, in the central nervous system, the detection of the faster 
diffusion of water molecules through the neuronal axons and the preparation of maps of 
neuronal tracts through the white matter [62]. To our knowledge, Single Wall Carbon 
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Nanotubes are the first agent communicated to induce differential diffusion of the water 
molecules with a predominant direction oriented through the longitudinal axis of the 
nanotube, allowing in this way to induce exogenous contrast in Diffusion Tensor 
Images [63]. 
Spectroscopic methods 
pH sensors 
The potential to determine pH from MRS measurements was soon realized [64-
66]. Briefly, it is possible to measure pH from the changes in chemical shift of a proton 
(or other magnetically active nucleus) located in or close to an ionisable group in a 
molecule. In a general reaction of the type 
A- + H+ → AH 
where A- and AH represent the anionic and acidic forms, characterized by chemical 
shifts δA- and δAH,  pH may be calculated from the expression, 
pH = pKa + log ((δ-δA)/(δAH-δ))   (4) 
where pKa represents the pKa of the ionisable group in A and δ the observed chemical 
shift of the pH sensitive proton. The most useful probes in vivo, are those with pKa 
values in the vicinity of physiological pH, in the 6.5-7.5 range. The larger the chemical 
shift interval between δA y δAH, the better the pH resolution from the δ measurement. 
The intra- or extracellular location of the pH probe allows for the measurement of either 
intra- or extracellular pH. Inorganic phosphate and phosphonate derivatives, have been 
classically used as intra- or extracellular probes in 31P NMR [67,68], while non 
permeant imidazolic derivatives were implemented more recently to measure 
extracellular pH with the inherently increased sensitivity and spatial resolution provided 
by 1H NMR [69]. The imidazolic H2 proton, reflecting the ionization state of the N3 
nitrogen, is normally used for these purposes since; (i) it is conveniently located in the 
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aromatic region and thus, not interfering with the endogenous metabolite resonances 
and (ii) depicts a relatively large chemical shift variation of ca. 1ppm in the 
physiological pH range [70]. 
pO2 sensors 
< Figure 5, near here> 
Nitroimidazoles have been classically used as probes to detect hypoxia in a 
variety of imaging modalities including MRI (19F and 1H), PET (Figure 8b),[71,72] 
SPECT [73] and optical methods (Figure 8c)[74,75].  
Briefly, the nitro group depicts a redox potential similar to NAD(P)H and is 
reduced in vivo under hypoxic conditions to very unstable hydroxylamine or amine 
derivatives that react easily with intracellular electrophiles to form adducts [76]. The 
chemical reduction of hydroxylamine derivatives and the subsequent chemical 
transformations have also been investigated [77,78], however the precise mechanism of 
nitroimidazole reduction in vivo remains still incompletely understood. 
Several attempts have been made to design rationally an optimized oxygen 
sensor based on nitroimidazole derivatives. The structure of most nitroimidazole based 
sensors (Figure 5a) may be divided in two parts: the nitro moiety and the lateral chain. 
The former is linked to an aromatic ring (usually imidazole) and is responsible of 
bioreduction of the molecule. The lateral chain is responsible of biodistribution, tissue 
penetration, elimination rate, etc.[79], carrying in most cases the “chromophore atoms” 
(19F, 18F, 125/123I, 99mTc). The general properties of these molecules may be, thus, fine 
tuned for specific purposes by modifying appropriately either the imidazol ring or the 
lateral chain, respectively. The improvements achieved may include: enough solubility 
in aqueous medium balanced with and adequate lipophilicity, stability and more feasible 
syntheses.  
 15
 
Hyperpolarized sensors 
Spectacular increases in 13C NMR sensitivity of up to 10.000 times have been 
obtained by hyperpolarizing 13C enriched substrates opening an avenue to 13C imaging 
of endogenous metabolites in health and disease [80-82]. Several hyperpolarization 
strategies have been described including the Brut Force method, the Optical Pumping 
method, the Parahydrogen method and the Dynamic Nuclear Polarization (DNP) 
method [83,84]. Of these the most relevant for environmental purposes is the DNP 
method. The technique is based in the transfer of electronic magnetization from a 
Gd(III) to the 13C nucleous, in the solid state and at very low temperature (4K), with the 
help of a suitable catalyst. The hyperpolarized 13C molecule can then be transferred into 
solution [85], injected in animals or administered to cells, and its metabolism followed 
kinetically by 13C NMR and resolved in space by 13C MRSI [86], for a period as long as 
the hyperopolarized state lasts, normally less than 200 s. Endogenous HCO3- is 
normally observed after the administration of (1-13C) pyruvate or (1-13C) lactate, after 
decarboxilation by pyruvate dehydrogenase in the tricarboxylic acid cycle [87,88]. The 
carbonic anhydrase equilibrium (Eq. 5) is sensitive to pH, making it possible to 
determine pH from the relative intensities of the resonances of 13CO2 and 13CO3H- 
resonances [89,90];. 
CO2 + H2O    ↔     CO3H- + H+   (5) 
 
 
4. PARAMEGNETIC AGENTS 
 
pH sensors 
Relaxivity probes 
<Figure 6, near here> 
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Complexes showing pH dependent relaxivity are of particular interest since they 
may afford to distinguish rather easily, cancerous or ischemic tissues (pHe = 6.6-6.9) 
from the surrounding healthy tissue (pHe = 7.2). In these cases, the protonation of a 
donor atom (O or N) in the complex may change the conformation of the pending arms 
and allow for competitive binding of an additional water molecule, increasing in this 
way the q value and the relaxivity of the complex. The first generation of paramagnetic 
complexes revealing pH changes consisted of Gd(III)DOTA derivatives containing 
amide or phosphonate pending arms [91,92]. Gd(DOTAM-MP)3+ (Figure 6A) [92] 
shows several pH jumps in its relaxivity between pH 3 and 8. NMR studies indicate that 
Ln(III) ion is bound by the four amide O-atoms and the four N-atoms of the cyclen 
backbone and that the first coordination sphere is completed by a water molecule. The 
phosphonate groups are not coordinated to the Ln(III) ion and are responsible of the pH 
dependence. This is so because the pKa of phosphonates is in the physiological range, 
making these agents to show pH dependent relaxivity, through the opening or closing of 
the phosphonate structure. This circumstance facilitated or hampered water contact with 
the Gd(III) core and thus sensitized to pH the relaxivity value. Calibration of the 
dependence of relaxivity with pH allowed the determination of pH from relaxivity 
measurements. An important limitation of the method was, however, that relaxivity of 
the CA was dependent also on the CA concentration, making it difficult to discriminate 
in vivo if the observed change in relaxivity was derived from a change in pH or a 
change in the concentration of the probe. In spite of this, valuable measurements of 
extracellular pH were performed after dual administration of pH responsive and non 
responsive agents [93-95] or through the application of T1/T2 ratiometric methods [96]. 
In a different approach (Figure 6B), the binding of water molecules to the 
paramagnetic center under ambient conditions is prevented by the interaction of 
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hydrogen carbonate with the metal ion in a macrocyclic tetraazatriamide complex, 
Gd(DO3A-Ala) [91,97]. In an acidic medium (pH < 6), the hydrogen carbonate ion will 
be protonated and displaced by two water molecules resulting in an increase of the 
complex relaxivity. Finally, metabolites other than protons and water may be imaged 
using the important effects on the relaxivity of Gd(III) DO3A induced by lactate or 
inorganic phosphate, provided the effects of agent concentration can be corrected [98]. 
PARACEST probes 
The use of the pH dependence of the rate constant for Chemical Exchange 
between water and an ionizable group of the agent has been used recently to measure 
pH and other environmental factors by Magnetization Transfer methods [16,99-101]. 
This approach overcomes one of the most important limitations of the relaxivity 
method, making the measurement independent of the concentration of the agent utilized. 
Upon saturation of the exchangeable resonance, a decrease is observed in the intensity 
of the free water resonance that is proportional to the rate constant of exchange between 
both sites, and thus to pH. The initial pH sensitive diamagnetic agents (DIACEST), as 
barbituric acid, required large concentrations (ca 60 mM) for an appreciable effect on 
the MR image [58,59] although protocols to decrease the large concentrations required 
have been proposed more recently [102]. An interesting variant of this method used 
endogenous polypeptides, whose large number of pH sensitive, water exchanging, 
amide bonds (Amide Proton Transfer, APT) decreased drastically the polypeptide 
concentration necessary to observe the magnetization transfer (MT) effect [53,55,57]. 
As mentioned above, an important limitation of the pH measurement by DIACEST 
methods is the restricted dynamic range of rate constants obtainable, derived from the 
“slow exchange” limitation between resonances separated only by  ca. 3 ppm. 
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DIACEST molecules were soon followed by the PARACEST probes, 
comprising basically complexes with different lanthanides and ionizable groups, 
depicting enormous “paramagnetic shifs” Δω (ca. -50 ppm), exchanging magnetization 
with the surrounding water in a pH dependent manner (Figure 6C) [16,103]. Weakly 
paramagnetic complexes from amide cyclen derivatives have shown to act as suitable 
MT contrast agents (Figure 6C). The Eu(III) complex from ligand 1 has a bound-water 
resonance near δ = 50 ppm, with an exchange lifetime of approximately 350 μs, acting 
as a powerful PARACEST agent [100]. The corresponding complexes of 3 with lighter 
Ln(III) ions (Pr, Nd, and Eu) are also pH responsive “single-molecule CEST agents” 
[100]. The Yb(III) complex from 1 with eight exchangeable, hyperfine-shifted amide 
protons, is reported as a prototype of high-sensitivity MT agent [92] .  
Eu(III) complexes of cyclen-based ligands have been proposed additionally as 
glucose and lactate sensors by CEST imaging detection [100,104,105]. Both, the free 
ligands and their Eu(III) complexes bind selectively simple sugars, with different 
binding affinities depending on the sugar structure. Recently, nitric oxide has been 
added to the molecules potentially detectable by CEST agents [106]. Finally, a variety 
of PARACEST probes have been proposed to detect in vivo temperature [107,108]. 
The CEST and APT methods, although brilliantly performing in vitro, present 
also some difficulties of interpretation in vivo. In particular, the intra- or extracellular 
origin of the MR effect (or pH measurement) is difficult to establish, since the 
magnetized water molecule that exchanges with the probes may move in and out of the 
cell during the imaging time, resulting in an averaged contribution of these two different 
environments to the pH value determined. In addition, the possibility that additional 
magnetization exchanges occur between water molecule and other endogenous 
ionizable groups from the tissue, cannot be completely excluded, probably masking in 
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part an accurate pH measurement. Finally, since pH dependent exchange is a diffusion 
limited process, local changes in the apparent diffusion coefficient of water could 
contribute as well to the pH measurement, introducing additional sources of uncertainty 
on the accuracy of the pH value measured in vivo using this method. 
Other probes  
In addition to pH, the cyclen structure may be sensitized to a variety of 
additional circumstances including Ca2+, enzyme activity, gene expression, temperature, 
lactate or glucose, providing the most versatile platform currently available for 
environmental studies. Interestingly, Meade and co-workers reported a calcium 
sensitive contrast agent, Gd2(DOPTA) [45]. The ligand consists of two DO3A units that 
are linked via an EGTA [29] type spacer carrying two aromatic iminodiacetate groups. 
In the absence of Ca2+, the iminoacetate functions are coordinated to the Gd(III) ions 
which under these conditions are inaccessible to water. However, in the presence of 
Ca2+, the carboxylate groups rearrange to bind this ion and two vacant coordination sites 
on each of the Gd(III) ions are now able to bind water molecules. This results in an 
increase in the relaxivity from 3.26 to 5.76 s-1 mM-1. 
MR images from healthy and diseased tissues would greatly benefit from the 
detection of gene expression in vivo [109,110]. The first contrast agent reporting 
enzyme activity described in the literature was Gd(DO3A-gal), a DOTA type ligand in 
which one of the carboxylate groups is replaced by a galactose moiety [46,[111]. The 
galactose moiety protects the metal ion from water binding. As soon as the enzyme β-
galactosidase cleaves off the sugar, [Gd(DOTA)]- is formed with the inner sphere 
accessible for the coordination of a water molecule, with the consequent increase in 
relaxivity. Since many exogenously administered genes carry the flanking β-
galactosidase gene, expression of these transgenes may be monitored by monitoring in 
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this way the expression of the β-galactosidase enzyme in vivo. Additional approaches 
have been proposed for the expression of iron binding proteins or transporters able to be 
activated by endogenous iron accumulation [112,113] as well as novel gene expression 
amplification strategies to improve MRI visualization of the overexpressed genes [114]. 
 
4. DIAMAGNETIC AGENTS 
Imidazole derivatives 
Spectroscopic pH responsive probes 
< Figure 7, near here> 
To overcome some of the limitations of paramagnetic probes, we proposed some 
years ago the development of a novel series of diamagnetic agents to determine 
extracellular pH using the alternative Magnetic Resonance Spectroscopy approach 
[20,21]. 3-(Ethoxycarbonyl)-2-imidazol-1-ylpropionic acid, abbreviated as IEPA 
(Figure 7), was the first probe synthesized in our laboratories already in 1992, that made 
possible the non-invasive in vivo measurement of pHe in tumours using of the 1H-NMR 
Spectroscopic Imaging (1H MRSI) method [22]. We selected the imidazole ring in the 
design of IEPA basically for two reasons: i) the imidazole pKa (ca. 7.0) is very close to 
physiological pH allowing accurate pH measurements, and ii) its H-2, H-4 and H-5 
proton resonances are easily resolved and observed in the aromatic region of 1H NMR 
spectra, sufficiently far away from the water and the crowded aliphatic regions of the 
spectrum.  
< Figure 8, near here> 
Figure 8 illustrates the method with one the earliest pH images obtained. After 
infusing IEPA in rat bearing a C6 glioma, it was possible to observe the resonances 
from the H2 proton of the pH probe, only in the tumoral region [115,116]. This is 
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because IEPA is a non permeant probe and the tumor vasculature is devoid of blood 
brain barrier, allowing IEPA to diffuse directly into the extracellular space. Calibration 
of the pH dependence of the H2 chemical shift, allowed then to determine extracellular 
pH. H2 Multiple, localized, pHe measurements using this probe were conveniently 
obtained by determining the chemical shifts of its imidazolic H-2 proton in the 
collection of contiguous voxels provided by the 1H MRSI experiment. It was possible 
then to demonstrate for the first time that extracellular pH is heterogenous through the 
tumor (Figure 8f).  
 The same 1H MRSI approach, with a longer echo time (120 ms), could be used 
to obtain maps of other endogenous metabolites of the C6 glioma, allowing for the first 
time to establish correlations between extracellular pH and the local concentrations of 
the different metabolites imaged. The correlation found between the lactate resonance 
and the extracellular pH in vivo entailed particular physiological relevance. The 
classical work of Warburg had revealed that tumors produced larger amounts of lactate 
than normal tissues, indicating that extracellular lactate could be the main cause of 
extracellular tumor acidity. Our results in vivo, revealed no significant correlation 
between extracellular pH and the lactate resonance, indicating that either protons diffuse 
faster than lactate from the lactate production sites or, that tumors present additional 
sources of protons to lactate. We confirmed recently this observation using ISUCA, an 
improved pH indicator based on the IEPA structure but providing increased blood 
retention time and augmented pH resolution [116]. In summary, the use of diamagnetic 
pH probes and in vivo MRSI provides a good illustration of the important differences 
between metabolism as investigated in isolated cells or tissues or in vivo, illustrating the 
enormous potential of accurate pH measurements by 1H MRSI as a new diagnostic and 
prognostic tool in oncology. 
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Spectroscopic pO2 responsive probes 
Varghese et al. reported firstly, to our knowledge, that -14C labeled- 
misonidazole was selectively trapped in oxygen deficient cells [117]. Various attempts 
have been reported using nitroimidazole based drugs as 19F-NMR oximetry probes. 
Early work carried out by Raleigh et al. using CCI-103F showed the ex vivo 
detectability of bounded derivatives in tumour and liver by 19F-NMR [118]. Later on, 
the ex vivo the concentration of bound marker in different types of subcutaneous tumour 
(R3327 H or R3327 AT prostatic adenocarcinomas and walker 256 carcinoma) and in 
liver was quantified using 19F-NMR [119]. 
More recently, two fluorinated nitroimidazole derivatives, SR-4554 and TF-
MISO (Figure 5A) have been used to measure hypoxia in vivo. The former has been 
extensively studied both in vitro [120] and in vivo with different tumour types [121] 
showing low toxicity, high metabolic stability, favourable pharmacokinetics and high 
sensitivity for detection by magnetic resonance spectroscopy[122]. A close relationship 
between retention of SR-4554 and polarographic pO2 electrode measurements in rat 
bearing P22 carcinosarcoma has been reported [123]. SR-4554 has recently entered in 
Phase I clinical trials showing promising pharmacokinetic and toxicity profiles, 
although no oxygenation measurements have been reported to date, to our knowledge, 
in patients [124]. 
TF-MISO has been proposed as a plausible 19F-NMR nitroimidazole based 
reporter [125]. A positive correlation is found in vivo between the corresponding 
retention index and the tumour volume (qualitatively related with tumour hypoxia). It is 
important to notice that multivoxel spectroscopy has been achieved in tumours in vivo, 
showing that TF-MISO is visible under these conditions. Based on spectroscopy 
measurements, tumor hypoxic fraction was calculated, finding similar results with 
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literature values for MCa tumors. Although this methodology remains still far from 
being clinically applicable, it represents an important advance since it proves for the 
first time that a nitroimidazole based drug may be spatially resolved by multivoxel 
spectroscopy in vivo. 
Hyperpolarized probes 
<Figure 9, near here> 
The use of hyperpolarized 13C methods and 13CO3H- to measure metabolic 
fluxes and pH in vivo is well illustrated recently in the studies from the Cambridge, 
Oxford and Dallas groups [89,126-129]. The method allows to measure pH from the 
ratio of 13CO2/CO3H
- resonances, maintained in, or near equilibrium, by carbonic 
anhidrase. Figure 9 illustrates the pH results obtained in vivo in an implanted lymphoma 
after the administration of hyperpolarized (1-13C) pyruvate using 13C MRSI. The 
resolution is comparable to that obtained by 1H MRSI, but its applicability remains at 
present limited to few research sites because the large and specialized infrastructure 
required. An important concern in this case may arise from the characterization of intra- 
or extracellular environments originating the observed 13CO2 or HCO3
- resonances, 
because the ubiquitous location of these two metabolites in vivo. However, it appears 
reasonable to believe that value of pH measured by hyperpolarized techniques refers 
primarily to the intracellular compartment, since it correlates well in the heart with 31P 
NMR measurements of pHi using the inorganic phosphate measurement. 
 
5. CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
The present review addressed briefly the use of MRI or MRS probes to obtain 
measurements of microenvironmental variables as pH and pO2 in vivo. MRI active 
contrast agents provide values of these variables with high spatial resolution. However, 
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the possibility that MRI measurements include contributions from environmental factors 
additional to those being investigated, such as transcellular water exchange or limited 
diffusion between intra- and extracellular spaces, should not be ignored. In contrast, 
diamagnetic probes for spectroscopic imaging provide measurements of extracellular 
pH with lower resolution, but entailed with a more robust, unambiguous interpretation. 
The recent improvements of the available agents using magnetically equivalent dimer 
molecules [26], together with the rapidly increasing magnetic fields available for 
spectroscopy promise to improve in the near future the resolution of the MRSI 
experiments approaching the MR imaging limits.  
In virtually all previous cases, paramagnetic or diamagnetic agents have been 
used in separate. Necessary cross-validations of the measurements need them to be 
applied in combination in the same experimental model. Moreover, the combination of 
the optimized pHe diamagnetic probes with recently synthesized pO2 probes [27], and 
PARACEST probes sensitive to glucose or lactate concentrations may afford, in the 
near future, for the integral evaluation of the various environmental factors in normal 
and diseased tissues by MRI/MRS methods. The spectacular improvements in the use of 
13C hyperpolarized probes promise to unravel the relationships between pH and pO2 
measurements and the activity of crucial enzymes of energy metabolism as pyruvate 
dehydrogenase or lactate dehyrogenase. It is also possible to think that some the 
diamagnetic probes currently available may become 13C enriched and hyperopolarized 
in the future, further enlarging the arsenal of hyperpolarized environmental probes. 
Finally, the Blood Brain Barrier remains as one of the most important challenges to 
allow these probes to reach and investigate the extracellular environment of the healthy 
brain in vivo. Structural improvements are expected to increase significantly the pass of 
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environmentally sensitive probes through the barrier into the extracellular compartment 
of the healthy or diseased brain. 
In summary, the present review has shown that imaging the tissue 
microenvironment in vivo is feasible and has demonstrated great potential in animal 
models of disease, its transfer to the clinic remaining at present the most important 
challenge for future developments in this field. 
 
ACKNOWELEDGEMENTS 
This work was supported in part by grants: CTQ2006-06505/BQU, CTQ2009-14146-
C01/C02, to P.B. and P.L.L., S-BIO/0179/2006 and SAF2008/01381 to SC and EU 
MEDITRANS Integrated Project NMP4-CT-2006-02668 to S.C., P.L.L. and P.B. J. P-
T, D. C., B.L. and V.N. are predoctoral fellows from the Community of Madrid and 
CSIC and V.N. and C.U hold contracts from UNED. Authors are indebted to Mr. Javier 
Pérez for carefully drafting the illustrations. 
 
ABBREVIATIONS 
T1 :   Longitudinal Relaxation time 
T2 :   Transversal relaxation time 
T2* :   Transversal relaxation time including magnetic field inhomogeneity 
r1 :  Longitudinal relaxation rate 
r2 :  Transversal relaxation rate 
r2* :  Transversal relaxation rate including magnetic field homogeneity effects 
ADC :  Apparent Diffusion Coefiicient 
MT :  Magnetization Transfer 
MRSI:  Magnetic Resonance Spectroscopic Imaging 
CEST:  Chemical Exchange Saturation Transfer 
DIACEST:  Diamagnetically Induced Chemical Exchange Saturation Transfer 
PARACEST: Paramagnetically Induced Chemical Exchange Saturation Transfer 
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APT:   Amide Proton Transfer 
DTPA: Diethylen diamino pentaacetic acid 
DNP:   Dynamic Nuclear Polarization 
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FIGURE LEGENDS 
Fig. (1). The extracellular microenvironment of tissues (light blue) is located between 
the vascular (red) and intracellular (grey) spaces. A: Under normal conditions (A) it is 
characterized by relatively low concentrations of lactate and H+ due to the efficient 
removal of these metabolic products by the microvasculature. B: Reduced performance 
of the microvasculature (purple) under most pathological situations results in lactate and 
H+ accumulation among other waste products in the diseased extravascular space 
(brown). This review describes the different approaches developed to progress from 
conventional anatomical T2 weighted MR images (inset A) to molecular images 
revealing particular properties of the extracellular environment as pH in the brain of rat 
bearing a C6 tumor (inset B). 
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Fig. (2). Fundamentals of paramagnetic water relaxation induced by Gd(III) chelates. 
The ccordination envelope of cyclen ligands occupy eight (1-8) of the nine coordination 
sites from Gd(III), allowing a single water molecule to enter the vacant site of the metal. 
Under these conditions, the T1 of the coordinated water molecule is reduced to T1m, this 
molecule being able to exchange with the solvent with an exchange rate kex and 
experience then Brownian diffusion (ADC). The ability of the complex to induce faster 
water relaxation rates r1,2,2* (known as relaxivities) may be improved by increasing the 
number of coordinated water molecules (q>1), slowing down the rotational correlation 
timer of the complex (τR) through binding to macromolecular carriers, or increasing the 
exchange rate kex between the solvent and the first coordination sphere. Faster ADC 
improves the amplification of the inner sphere relaxivity effects. 
 
Fig. (3). Magnetization Transfer Contrast. Tissue water may be present primarily in two 
different environments, “bound” (dark blue) as solvation water to different biomolecues 
(BM) or “free” (light blue) as solvent. Water molecules exchange (kex) between these 
two environments (A). Saturating the “bound water” resonance with an selective Rf 
pulse (Rf) results in a decrease of the original water resonance from (Mo) to (Msat), 
because the saturated spins are transferred to the solvent (B). This exchange is 
influenced by additional environmental factors including temperature, pH and the 
Apparent Diffusion Coefficient (ADC). Lower panels: Representative saturation 
transfer images from rat bearing a C6 grioma; (C) T2 weighted image before the 
saturation pulse, (D) after the saturation pulse and (E) Magnetization Transfer Msat/Mo 
map.  
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Fig. (4). In vivo measurements of the Apparent Diffusion Coefficient (ADC) by in vivo 
MRI allow to probe tissue microstructure. A: The classical Stejstahl-Tanner sequence. 
δ: duration of the diffusion encoding gradient. Δ: Diffusion measurement time. Pixel by 
pixel measurements of the signal intensities obtained for increasing diffusion gradient 
values allow the determination of the pixel by pixel ADC map of  a representative rat 
brai bearing a C6 glioma (D). During the same Δdiff tissue water will diffuse longer 
paths in less cellularly crowded (B) than in more cellularly crowded environments (C). 
 
Fig. (5). Imidazolic pO2 probes. A: Some imidazole derivatives currently used as 
oxygen probes by PET (18F-Fluoromisonidazol), optical methods (Pimonidazol) and 
19FMRI/MRS (EF5 and TF-MISO). B: Comparison of PET images from the uptake of 
FDG glucose (left) or 18F-Fluoromisonidazol (right). Note that only one of the nodules 
positive to FDG is hypoxic as revealed by F-MISO. C:  Fluorescence micrograph from a 
head and neck squamous carcinoma showing pimonidazol accumulation in the hypoxic 
areas (green) surrounding the necrotic core. D: Retention maps of TF-MISO as detected 
by 19F MRSI showing hypoxic areas (right inset) and 19F spectra showing the 
accumulation of TF-MISO only in the hypoxic zones (left inset). Illustrations are taken 
from refs [130], [131] and [132] and reproduced with permission of the publisher. 
 
Fig. (6). Structures of ligands derived from the cyclen structure useful as pH sensors 
using relaxivity enhancement (A and B) or PARACEST methods (C). 
 
Fig. (7). Structures of imidazolic derivatives currently used as extracellular pH probes. 
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Fig. (8). Extracellular pH maps obtained with IEPA from implanted C6 gliomas. A and 
B: 1H NMR PRESS spectra from the contralateral and ipsilateral hemispheres. Note that 
IEPA only accumulated in the tumor. C: Gd(III) DOTA enhanced image of the same C6 
tumor showing peripheral enhancement of the vascularised regions. D: 1H MRSI image 
of IEPA accumulation in the tumor. E. Titration of the pH dependence of the imidazolic 
H2 proton from IEPA. F: Extracellular pH map obtained from the chemical shift of 
IEPA H2 resonance observed in the tumor. Reproduced from ref. [115] with permission 
of the publisher. 
 
Fig. (9). Imaging the tumor pH in vivo by 13C MRSI using hyperpolarized 13CO3H-/CO2. 
A: T2 weighted image showing the EL4 tumor localization B: pH map calculated from 
the intensity maps of HCO3- (C) and CO2 (D). Reproduced from ref [126] with 
permission of the publisher. 
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